News & Trends - MedTech & Diagnostics
Roche diabetes monitoring products to be sold in Woolworths
MedTech News: Roche Diabetes Care Australia has announced that a range of diabetes monitoring products will soon be available in Woolworths.
Products including Accu-Chek Instant S blood glucose meters, Accu-Chek Instant test strips and Accu-Chek Softclix lancing products, will be nationally available in the Health Aisle at Woolworths from March 2020.
Jane Crowe, General Manager, Roche Diabetes Care Australia noted that while the local pharmacy remains the key access point for products that are reimbursed via the National Diabetes Services Scheme (NDSS) and to seek advice, for the many Australians who are not managing their diabetes effectively, Roche did not want access to be a barrier.
“We are committed to innovation, not only in our product development, but also in ways in which consumers can access them. Given this range is not reimbursed via the NDSS, no form is required to purchase the products, enabling us to establish the partnership with Woolworths and broaden availability,” said Ms Crowe.
A spokesperson for the Pharmacy Guild of Australia said “This is a regrettable retrograde step. Distribution of these products through supermarkets will separate patients from the professional care and advice that is so important to the proper management of diabetes.”
Diabetes is the fastest growing chronic condition in Australia. There are currently 1.7 million Australians are living with diabetes and a further 280 people diagnosed each day.
Enhance corporate branding and boost thought leadership to attract and retain quality employees. How does your company culture and digital footprint measure up in the Australian Medical Devices industry? Get the benchmark report by contacting us.
Register FREE to receive the latest industry news, innovations and insights from Health Industry Hub; the only one-stop-hub connecting Australia’s Pharma, MedTech and Biotech industry professionals and its key stakeholders.
News & Trends - MedTech & Diagnostics
Pathology reforms: Frozen fees, windfall gains, and the fight for bulk-billing
Diagnostics & MedTech News: For nearly a quarter-century, pathology fees have remained stagnant, a situation deemed patently unfair by Australian […]
MoreNews & Trends - Pharmaceuticals
Call for coordinated policy and cross jurisdiction funding in chronic disease
Pharma News: The life expectancy of Australians is still rising, however the increased prevalence of chronic conditions and co- and […]
MoreNews & Trends - MedTech & Diagnostics
Expansion of hospital services for patients in NSW Macarthur region
MedTech & Diagnostics News: Marking a historic milestone with NSW Deputy Premier Prue Car and Health Minister Ryan Park, Campbelltown […]
MoreNews & Trends - Biotechnology
Superiority of cell-based flu vaccine revealed in RWE study
Biotech News: Vaccines stand as the primary strategy to mitigate the considerable morbidity, mortality, and economic burden associated with influenza. […]
More